RxeLite Inc.

RxElite Inc. is a specialty pharmaceutical company focused on developing, manufacturing, and marketing generic prescription drug products for niche segments within the broader healthcare industry. The company's primary emphasis is on specialty generic markets, with a portfolio that includes anesthesia gases, sterile liquid dose formulations (such as ophthalmic products), sterile inhalation and respiratory therapies, injectable drugs, and active pharmaceutical ingredients (APIs). RxElite Inc. serves a diverse client base comprised of hospitals, hospital group purchasing organizations, national and regional drug wholesalers, retail pharmacy chains, homecare companies, and ambulatory surgical centers. The company has also expanded its capabilities through strategic acquisitions, notably FineTech Laboratories, enhancing its ability to supply APIs. By concentrating on specialty generics, RxElite Inc. addresses critical needs for cost-effective and high-quality pharmaceuticals in complex therapeutic areas, reinforcing its role as a significant supplier within the specialty healthcare and pharmaceutical distribution space.